본문 바로가기
KERD
논문KCI 등재후보

Immobilization Osteoporosis

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류기타의약학

초록

Immobilization osteoporosis is found in a number of diseases, such as complete motor paralysis and reversible immobilization. In general, immobilization-induced mechanical loading declines in bones are known to be among the key factors of osteoporosis in spinal cord injury, stroke, and bed rest patients. However, recent research has also identified non-mechanical factors, including neural, endocrine, hormonal, nutritional, and iatrogenic factors. Prevention and treatment of immobilization osteoporosis can be divided into pharmacological and non-pharmacological methods. Pharmacologic treatments such as calcitonin, bisphosphonates, and oral phosphates have been applied to patients with spinal cord injury or under bed rest conditions to reduce bone loss. Recently, researchers have examined zoledronic acid, which has a positive impact on the prevention and treatment of acute stroke and spinal cord injury. Zoledronic acid is an intravenous bisphosphonate given once a year, thereby bypassing gastrointestinal absorption/irritation problems. However, several questions still remain, including whether bone loss should continue in immobilized patients with spinal cord injury or stroke, how long bone mineral density levels can remain intact after treatment, and how long the treatment should continue. As such, more extensive research that studies these questions in the long term is needed.

Abstract

Immobilization osteoporosis is found in a number of diseases, such as complete motor paralysis and reversible immobilization. In general, immobilization-induced mechanical loading declines in bones are known to be among the key factors of osteoporosis in spinal cord injury, stroke, and bed rest patients. However, recent research has also identified non-mechanical factors, including neural, endocrine, hormonal, nutritional, and iatrogenic factors. Prevention and treatment of immobilization osteoporosis can be divided into pharmacological and non-pharmacological methods. Pharmacologic treatments such as calcitonin, bisphosphonates, and oral phosphates have been applied to patients with spinal cord injury or under bed rest conditions to reduce bone loss. Recently, researchers have examined zoledronic acid, which has a positive impact on the prevention and treatment of acute stroke and spinal cord injury. Zoledronic acid is an intravenous bisphosphonate given once a year, thereby bypassing gastrointestinal absorption/irritation problems. However, several questions still remain, including whether bone loss should continue in immobilized patients with spinal cord injury or stroke, how long bone mineral density levels can remain intact after treatment, and how long the treatment should continue. As such, more extensive research that studies these questions in the long term is needed.

참고문헌 (149)

  1. Albright F, "Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism", Clin Endocrinol, 1, pp.711~716 (1941)
  2. Whedon GD, "Disuse osteoporosis, in Bone as a Tissue", pp.67~99 (1960), McGraw Hill
  3. Whedon GD, "Metabolic studies in paralytic acute anterior poliomyelitis. If: Alterations in calcium and phosphorus metabolism", J Clin Invest, 36, pp.966~981 (1957)
  4. Deitrick JE, "Effects of immobilization upon various metabolic and physiologic functions in normal men", Am J Med, 4, pp.3~36 (1948)
  5. Minaire P, "Quantitative histological data on disuse osteoporosis: comparison with biological data", Calcif Tissue Res, 17, pp.57~73 (1974)
  6. Hattner RS, "Influence of weightlessness upon the skeleton: a review", Aerosp Med, 39(8), pp.849~855 (1968)
  7. Currey JD, "The mechanical adaptations of bones" (1984), Princeton University Press
  8. Frost HM, "The mechanostat: a proposed pathogenic mechanism of osteoporosis and the bone mass effect of mechanical and non-mechanical agents", Bone Mineral, 2, pp.73~85 (1987)
  9. Minaire P, "Quantitative histological data on disuse osteoporosis: comparison with biological data", Calcif Tissue Res, 17, pp.57~73 (1974)
  10. Krolner B, "Vertebral bone loss: an unheeded side effect of therapeutic bed rest", Clin Sci, 64, pp.537~540 (1983)
  11. Dalen N, "Bone mineral content and physical activity", Acta Orthop Scand, 45, pp.170~174 (1974)
  12. Margulies JY, "Effect of intense physical activity on the bone mineral content in the lower limbs of young adults", J Bone Joint Surg, 68(A), pp.1090~1093 (1986)
  13. Minaire P, "Acute osteoporosis in paraplegic patients: pathophysiology and effects of treatment with calcitonin and dichloromethylene diphosphonate, in Osteoporosis", pp.421~428 (1982), Wiley and sons
  14. Minaire P, "Immobilization bone loss: preventing effect of calcitonin in several clinical models, in Osteoporosis", pp.603~ (1987), Osteopress
  15. Chantraine A, "Bone remodeling during the development of osteoporosis in paraplegia", Calcif Tissue Int, 38, pp.323~327 (1986)
  16. Sheng-Dan J, "Osteoporosis after spinal cord injury", Osteoporosis Int, 17, pp.180~192 (2006)
  17. Sabo D, "Osteoporosis in patients with paralysis after spinal cord injury: a cross sectional study in 46 male patients with dual-energy X-ray absorptiometry", Arch Orthop Trauma sug, 121, pp.75~78 (2001)
  18. "2001", 83
  19. Kunkel CF, "Effect of “standing” on spasticity, contracture and osteoporosis in paralyzed males", Arch Phys Med Rehabil, 74, pp.73~78 (1993)
  20. Biering-Sorensen F, "Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury", Eur J Clin Inves, 20, pp.330~335 (1990)
  21. Brunin ED, "Long-term changes in the tibia and radius bone mineral density following spinal cord injury", Spinal Cord, 43, pp.96~101 (2005)
  22. Sabo D, "Osteoporosis in patients with paralysis after spinal cord injury: a cross-sectional study in 46 male patients with dual-energy X-ray absorptiometry", Arch Orthop Trauma Surg, 121(1), pp.75~78 (2001)
  23. Eser P, "Relationship between the duration of paralysis and bone structure: a pQCT study of spinal cord injured individuals", Bone, 34(5), pp.869~880 (2004)
  24. Zehnder Y, "Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men", Osteoporos Int, 15(3), pp.180~189 (2004)
  25. Minaire P, "Quantitative hisological data on disuse osteoporosis: comparison with biological data", Calcif Tissue Res, 17, pp.57~73 (1974)
  26. Modlesky CM, "Trabecular bone microarchitecture is deteriorated in men with spinal cord injury", J bone Miner Res, 19, pp.48~55 (2004)
  27. Szollar SM, "Demineralization in tetraplegic and paraplegic man over time", Spinal Cord, 35, pp.223~228 (1997)
  28. Slade JM, "Trabecular bone is more deteriorated in spinal cord injured versus estrogen-free postmenopausal women" (2004), Osteoporos Int
  29. Ragnarsson KT, "Lower extremity fractures after spinal cord injury: a retrospective study", Arch Phus Med Rehabil, 62, pp.418~423 (1981)
  30. Ingram RR, "Lower limb fractures in the chronic spinal cord injured patient", Paraplegia, 27, pp.133~139 (1989)
  31. Comarr AE, "Extremity fractures of patients with spinal cord injuries", AM J Surg, 13, pp.732~739 (1962)
  32. Vestergaard P, "Fracture rates and risk factors for fractures in patients with spinal cord injury", Spinal Cord, 36, pp.790~796 (1998)
  33. Frisbie JH, "Fractures after myelopathy: the risk quantified", J Spinal Cord Med, 20, pp.66~69 (1997)
  34. Finsen V, "Bone mineral and hormone status in paraplegics", Paraplegia, 30, pp.343~347 (1992)
  35. Garland DE, "Bone loss at the os calcis compared with bone loss at the knee in individuals with spinal cord injury", J Spinal Cord Med, 27, pp.207~211 (2004)
  36. Dauty M, "Supralesional and sublesional bone mineral density in spinal cord-injured patients", Bone, 27, pp.350~359 (2000)
  37. Hamdy RC, "Long-term effects of strokes on bone mass", Am J Phys Med Rehabil, 74, pp.351~356 (1995)
  38. Ramnermark A, "Progressive hemosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke", Osteoporos Int, 9, pp.269~275 (1999)
  39. Sato Y, "Increased bone resorption during the first year after stroke", Stroke, 29, pp.1373~1377 (1998)
  40. Jorgensen L, "Ambulatory level and asymmetrical weight bearing after stroke affects bone loss in the upper and lower part of the femoral neck differently: bone adaptation after decreased mechanical loading", Bone, 27, pp.701~707 (2000)
  41. Lazoura O, "Bone mineral density alterations in upper and lower extremities 12 months after stroke: a longitudinal study", Osteoporos Int, 11, pp.381~387 (2000)
  42. Ramnemark A, "Hemiosteoporosis after severe stroke, independent of changes in body composition and weight", Stroke, 30, pp.755~760 (1999)
  43. Worthen LC, "Beaupre GS. Key characteristics of walking correlate with bone density in individuals with chronic stoke", K Rehabil Res Dev, 42, pp.761~768 (2005)
  44. del Puente A, "Determinants of bone mineral density in immobilization: a study on hemiplegic patients", Osteoporos Int, 6, pp.50~54 (1996)
  45. Sato Y, "Development of osteopenia in the hemiplegic finger in patients with stroke", Eur Neurol, 36, pp.278~283 (1996)
  46. Prince RL, "Forearm bone loss in hemiplegia: a model for the study of immobilization osteoporosis", J Bone miner Res, 3, pp.305~310 (1988)
  47. Bainbridge NJ, "Bone loss after stroke over 52 weeks at os calcis: influence of sex, mobility and relation to bone density at other sites", Age Ageing, 35, pp.127~132 (2006)
  48. Iwamoto J, "Bone mineral density of metatarsus in hemiplegic subjects", Am J Phys Med Rehabil, 78, pp.202~207 (1999)
  49. Dennis MS, "Fractures after stroke: frequency, types, and associations", Stroke, 33, pp.728~734 (2002)
  50. Ramnemark A, "Fractures after stroke", Osteoporos Int, 8, pp.92~95 (1998)
  51. Worthen LC, "Key characteristics of walking correlate with bone density in individuals with chronic stroke", JK Rehabil Res Dev, 42, pp.761~768 (2005)
  52. Chiu KY, "A prospective study on hip fractures in patients with previous cerebrovascular accidents", Injury, 23, pp.297~299 (1992)
  53. Sander P, "Risk of hip", femur fracture after stroke: a population-based case-control study, 2009, pp.40, 3281~
  54. Krolner B, "Vertebral bone loss: An unheeded side effect of therapeutic bed res", Clin Sci, 64, pp.537~540 (1983)
  55. Kannus P, "Osteoporosis in men with a history of tibial fracture", J Bone Miner Res, 9, pp.423~429 (1994)
  56. Ohshima H, "Secondary osteoporosis update. Bone loss due to bed rest and human space flight study", Clin Calci, 20, pp.709~716 (2010)
  57. Sheng-Dan J, "Mechanisms of osteoporosis in spinal cord injury", Clinical Endocrinology, 65, pp.555~565 (2006)
  58. Ohshima H, "Bone metabolism in human space flight and bed rest study", Clin Calci, 18, pp.1245~1253 (2008)
  59. Stefano C, "Osteoporosis after stroke: a review of the causes and potential treatments", Cerebreasc Dis, 28, pp.191~200 (2009)
  60. Doty SB, "Morphological evidence of gap junctions between bone cells", Calcif Tissue Int, 33, pp.509~512 (1981)
  61. Lanyon LE, "Osteocytes, strain detection, bone modeling and remodeling", Calcif Tissue Int, 53, pp.102~107 (1993)
  62. Cowin SC, "Candidates for the mechanosensory system in bone", J Biomech Eng, 113, pp.191~197 (1991)
  63. Palumbo C, "Morphological study of intercellular junctions during osteocyte differentiation", Bone, 11, pp.401~406 (1990)
  64. Rodan GA, "Cyclic AMP and cyclic GMP: mediators of the mechanical effects on bone remodeling", Science, 189, pp.467~469 (1975)
  65. Duncan RL, "Mechanotransduction and the functional response of bone to mechanical strain", Calcif Tissue Int, 57, pp.344~358 (1995)
  66. Minaire P, "Quantitative histological data on disuse osteoporosis: Comparison with biological data", Calcif Tissue Int, 17, pp.230~235 (1974)
  67. Vico L, "Etude hisologique quantitative de la masse et des activites cellulaires osseuses après undecubitus de 120 jours. Essai de protocols preventives", Ann Bil Clin, 45, pp.145~151 (1987)
  68. Minaire P, "Quantitative histological data on disuse osteoporosis: comparison with biological data", Calcif Tissue Res, 17, pp.57~73 (1974)
  69. Rodan G, "Characterization and pharmacological control of immobilization induced bone resorption, in Osteoporosis", pp.762~763 (1987)
  70. Shinjiro T, "Disuse osteoporosis", J Med Invest, 48, pp.147~156 (2001)
  71. Einhorn TA, "Bone strength: the bottom line", Calcif Tissue Int, 51, pp.333~339 (1992)
  72. Frost HM, "Dynamics of bone remodeling, in Bone Biodynamics", pp.315~334 (1964), Little brown
  73. Jenny KB, "Immobilization osteopenia, in Osteoporosis", pp.207~226 (2001), Elsevier
  74. Maïmoun L, "Use of bone biochemical markers with dual energy X-ray absorptiometry for early determination of bone loss in persons with spinal cord injury", Metabolism, 51, pp.958~963 (2002)
  75. Roberts D, "Longitudinal study of bone turnover after acute spinal cord injury", J Clin Endocrinol Metab, 83, pp.415~422 (1998)
  76. Bergmann P, "Longitudinal study of calcium and bone metabolism in paraplegic patients", Paraplegia, 15, pp.147~159 (1977)
  77. Stewart AF, "Calcium homeostasis in immobilization: an example of resorptive hypercalciuria", N Engl J Med, 306, pp.1136~1140 (1982)
  78. Vaziri ND, "Parathormone and calcitonin profiles in persons with long-standing spinal cord injury", Arch Phys Med Rehabil, 75, pp.766~769 (1994)
  79. Demirel G, "Osteoporosis after spinal cord injury", Spinal cord, 36, pp.822~825 (1998)
  80. Tsuzuku S, "Bone mineral density differences between paraplegic and quadriplegic patients: a cross-sectional study", Spinal Cord, 37, pp.358~361 (1998)
  81. Garland DE, "Risk factors for osteoporosis at the knee in the spinal cord injury population", J Spinal Cord Med, 27, pp.202~206 (2004)
  82. Bergmann P, "Longitudinal study of calcium and bone metabolism in paraplegic patients", Paraplegia, 15, pp.147~159 (1978)
  83. Pilchonery G, "Urinary elimination of glycosaminoglycans during the immobilization osteoporosis of spinal cord injury patients", Clin Orthop, 174, pp.230~235 (1983)
  84. Maynard, FM, "Immobilization hypercalcemia in spinal cord injury", Archives of Physical Medicine and Rehabilitation, 58, pp.16~24 (1977)
  85. Kaplan PE, "Reduction of hypercalciuria in tetraplegia after weight-bearing and strengthening exercises", Paraplegia, 19, pp.289~293 (1981)
  86. Kaplan PE, "Calcium balance in paraplegic patients: influence of injury duration and ambulation", Archives of Physical Medicine and Rehabilitation, 59, pp.447~450 (1977)
  87. Claus-Walker J, "Calcium excretion in quadriplegia", Arch Phys Med Rehabil, 53, pp.14~20 (1972)
  88. Zhou XJ, "Effects of chronic spinal cord injury and pressure ulcer on 25(OH)-vitamin D levels", Journal of the American Paraplegia Society, 16, pp.9~13 (1993)
  89. Roberts D, "Longitudinal study of bone turnover after acute spinal cord injury", Journal of Clinical Endocrinology and Metabolism, 83, pp.415~422 (1998)
  90. Mechanick JI, "Parathyroid hormone suppression in spinal cord injury patients is associated with the degree of neurologic impairment and not the level of injury", Archives of Physical Medicine and Rehabilitation, 78, pp.692~696 (1997)
  91. Bauman WA, "Vitamin D deficiency in veterans with chronic spinal cord injury", Metabolism, 44, pp.1612~1616 (1995)
  92. Pietschmann P, "Increased serum osteocalcin levels in patients with paraplegia", Paraplegia, 30, pp.204~209 (1992)
  93. Vaziri ND, "Parathormone and calcitonin profiles in persons with long-standing spinal cord injury", Archives of Physical Medicine and Rehabilitation, 75, pp.766~769 (1994)
  94. Kohli A, "Risk factors for renal stone formation in patients with spinal cord injury", British Journal of Urology, 58, pp.588~591 (1986)
  95. Biering-Sorense F, "Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury", European Journal of Clinical Investigation, 20, pp.330~335 (1990)
  96. Schmid A, "Free plasma catecholamines in spinal cord injured persons with different injury levels at rest and during exercise", Journal of the Autonomic Nervous System, 68, pp.96~100 (1998)
  97. Sato Y, "Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients", Stroke, 7, pp.2183~2187 (1962)
  98. Sato Ym, "Effect of immobilization upon renal synthesis of 1,25- dihydroxy vitamin D in disabled elderly stroke patients", Bone, 24, pp.271~275 (1999)
  99. Sato Y, "Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients", Age Ageing, 28, pp.265~269 (1999)
  100. Fujimatsu Y, "Role of parathyroid gland on bone mass and metabolism in immobilized stroke patients", Kurume Med J, 45, pp.265~270 (1998)
  101. Sato Y, "Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke", J bone Miner Res, 15, pp.2487~2494 (2000)
  102. Liu M, "Osteoporosis in hemiplegic stroke patients as studied with dual-energy X-ray absorptiometry", Arch Phys Med Rehabil, 80, pp.1219~1226 (1999)
  103. Zerwekh JE, "The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects", J bone Miner Res, 13, pp.1594~1601 (1998)
  104. Ben M, "Does 12 weeks of regular standing prevent loss of ankle mobility and bone mineral density in people with recent spinal cord injuries", Aust J Physiother, 51, pp.251~256 (2005)
  105. De Bruin ED, "Changes of tibia bone properties after spinal cord injury: effects of early intervention", Arch Phys Med Rehabil, 80, pp.214~220 (1999)
  106. Alekna V, "Effect of weight-bearing activities on bone mineral density in spinal cord injured patients during the period of the first two years", Spinal Cord, 46, pp.727~732 (2008)
  107. Biering-Sorensen F, "Bone mineral content of the lumbar spine and lower extremities years after spinal cord lesion", Paraplegia, 26, pp.293~301 (1988)
  108. Saltzstein RJ, "Osteoporosis in spinal cord injury: using an index of mobility and its relationship to bone density", J Am Paraplegia Soc, 15, pp.232~234 (1992)
  109. Goktepe AS, "Does standing protect bone density in patients with spinal cord injury", J Spinal Cord Med, 31, pp.197~201 (2008)
  110. Sandrine Bourrin, "Physical exercise duing remobilization restores a normal bone trabecular network after tail suspension-induced osteopenia in young rats", J Bone Miner Res, 10, pp.820~828 (1995)
  111. Jones LM, "Intensive exercise may preserve bone mass of the upper limbs in spinal cord injured males but does not retard demineralization of the lower body", Spinal Cord, 40, pp.230~235 (2002)
  112. Goktepe AS, "Bone density loss after spinal cord injury. Elite paraplegic basketball players vs. paraplegic sedentary persons", Am J Phys Med Rehabil, 83, pp.279~283 (2004)
  113. Miyahara K, "Effect of sports activity on bone mineral density in wheelchair athletes", J Bone Moner Metab, 26, pp.101~106 (2008)
  114. Eser P, "Effect of electrical stimulation-induced cycling on bone mineral density in spinal cordinjured patients", Eur J Clin Invest, 33, pp.412~419 (2003)
  115. Shields RK, "Musculoskeletal plasticity after acute spinal cord injury: effects of long-term neuromuscular electrical stimulation training", J Neurophysiol, 95, pp.2380~2390 (2006)
  116. Shields RK, "Law LAF. Electrical induced muscle contractions influence bone decline after spinal cord injury", Spine, 31, pp.548~553 (2006)
  117. Clark JM, "Physiological effects of lower extremity functional electrical stimulation in early spinal cord injury: lack of efficacy to prevent bone loss", Spinal Cord, 45, pp.78~85 (2007)
  118. Dudley-Javoroski S, "Dose estimation and durveillance of mechanical loading interventions for bone loss after spinal cord injury", Phys Ther, 88, pp.387~396 (2008)
  119. Mohr T, "Increased bone mineral density after prolonged electrical induced cycle training of paralyzed limbs in spinal cord injured man", Calcif Tissue Int, 61, pp.22~25 (1997)
  120. Belanger M, "Electrical stimulation: can it increase muscle strength and reserve osteopenia in spinal cord injured individuals", Arch Phys Med Rehabil, 81, pp.1090~1098 (2000)
  121. Chen S-C, "Increases in bone mineral density after functional electrical stimulation cycling exercises in spinal cord injured patients", Disabil Rehabil, 27, pp.1337~1341 (2005)
  122. Bloomfield SA, "Bone mass and endocrine adaptations to training in spinal cord injured individuals", Bone, 19, pp.61~68 (1996)
  123. Demirel G, "Osteoporosis after spinal cord injury", Spinal Cord, 36, pp.822~825 (1998)
  124. Biering-Sprensen R, "Bone Mineral content of the lumbar spine and lower extremities years after spinal cord lesion", Paraplegia, 26, pp.293~301 (1988)
  125. Panin N, "Osteoporosis in hemiplegia", Stroke, 2, pp.41~47 (1971)
  126. Merli GJ, "Immobilization hypercalcemia in acute spinal cord injury treated with etidronate", Arch Intern Med, 144, pp.1286~1288 (1984)
  127. Carey D, "Calcitonin therapy in prolonged immobilization hypercalcemia", Arch Phys Med Rehabil, 66, pp.640~644 (1985)
  128. Meythaler J, "Successful treatment of immobilization hypercalcemia using calcitonin and etidronate", Arch Phys Med Rehabil, 74, pp.316~319 (1993)
  129. Minaire P, "Effects of clodronate on immobilization bone loss", Bone, 8, pp.63~68 (1987)
  130. Hulley SB, "Effect of supplemental calcium and phosphorus on bone mineral changes in bed rest", J Clin Invest, 50, pp.2506~2518 (1971)
  131. Schneider V, "Skeletal calcium homeostasis and countermeasures to prevent disuse osteoporosis", Calcif Tissue Int, 36, pp.151~154 (1984)
  132. Hantmann DA, "Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate", J Clin Endocrinol Metab, 36, pp.845~858 (1973)
  133. Coburn JW, "1-α- Hydroxyvitamin D2: a new look at an ‘old’ compound", Nephrol Dial Transplant, 11(3), pp.153~157 (1996)
  134. Sato Y, "Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1-alpha-hydroxyvitamin D3 and calcium supplementation", Stroke, 28(4), pp.736~739 (1997)
  135. William AB, "Effect of a vitamin D analog on leg bone mineral density in patients with chronic spinal cord injury", J of Rehabilitation Research & Development, 42, pp.625~634 (2005)
  136. Storm T, "Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis", N Engl J Med, 322, pp.1265~1271 (1990)
  137. Harris ST, "Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy", Am J Med, 95, pp.557~567 (1993)
  138. Sato Y, "Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis", Eur Neurol, 37, pp.225~229 (1997)
  139. Sato Y, "Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke", J of stroke and cerebrovascular diseases, 19, pp.198~203 (2010)
  140. CM Moran de Brito, "Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study", Spinal Cord, 43, pp.341~348 (2005)
  141. Sato Y, "Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: a randomized controlled trial", Movement disorders, 21, pp.924~929 (2006)
  142. Chappard D, "Effects of tiludronate on bone loss in paraplegic patients", J Bone Miner Res, 10, pp.112~118 (1995)
  143. Nance PW, "Intravenous pamidronate attenuates bone density loss after acute spinal cord injury", Arch Phys Med Rehabil, 80, pp.243~251 (1999)
  144. Sato Y, "Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke", Arch Intern Med, 165, pp.1743~1748 (2005)
  145. Sato Y, "Risedronate therapy for prevention of hip fracture after stroke in elderly women", Neurology, 64, pp.811~816 (2005)
  146. Bubbear JS, "Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury", Osteoporos Int (2010)
  147. Poole KE, "A single infusion of zoledronate prevents bone loss after stroke", Stroke, 38, pp.1519~1525 (2007)
  148. Poole KE, "Bone structure and remodeling in stroke patients: early effects of zoledronate", Bone, 44, pp.629~633 (2009)
  149. Sato Y, "Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: a randomized controlled trial", Movement disorders, 21, pp.924~929 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (15건)